

Moderik Healthcare is a growing pharmaceutical company in India offering a wide portfolio of quality healthcare products across multiple therapeutic segments. Based in Ambala, Haryana, the company operates with a strong focus on quality, innovation, customer satisfaction, and long-term business partnerships. Its product portfolio covers several dosage forms, including tablets, capsules, softgels, syrups, drops, ointments, gels, oils, granules, and powders.
For the Nephrology Medicine Company category, Moderik Healthcare can be presented as a pharmaceutical partner offering renal and supportive healthcare formulations within its broader pharmaceutical portfolio. The company works with certified manufacturing facilities and states that its products follow ISO and WHO-GMP quality standards. Its quality-focused approach includes the use of high-grade raw materials, advanced manufacturing practices, and product testing before distribution.
Moderik Healthcare also provides PCD Pharma Franchise and third-party manufacturing solutions, supporting distributors, medical representatives, pharma professionals, and entrepreneurs looking to expand their pharmaceutical business. The company offers monopoly marketing rights, promotional materials, marketing assistance, and a broad range of therapeutic products.
With its experienced management team, extensive pharmaceutical portfolio, quality-driven operations, and customer-focused approach, Moderik Healthcare continues to develop its presence in India's healthcare sector and build long-term relationships with pharmaceutical business partners.
Moderik Healthcare emphasizes stringent quality control through high-grade raw materials, certified manufacturing facilities, advanced processes, and product testing to maintain safety, purity, and consistency.
To provide quality and innovative healthcare products while maintaining ethical business practices and creating meaningful value for customers, partners, employees, and society.
To build transparent and sustainable healthcare operations while expanding access to quality pharmaceutical products and creating long-term value for business partners and society.
N/A